Full Text (PDF)
Original Article

Efficacy of Dexmedetomidine on Blood Pressure in Patients Undergoing Laparoscopic Surgery

P.A. Nazar, Assistant Professor, Department of Anesthesiology, Kerala Medical College, Mangode, Palakkad, Kerala 679503, India. , P.A. Nazar

Author Information

Licence:




Indian Journal of Anesthesia and Analgesia 4(3):p 857-863, July - September 2017. | DOI: http://dx.doi.org/10.21088/ijaa.2349.8471.4317.51

How Cite This Article:


Timeline

Received : N/A         Accepted : N/A          Published : N/A

Abstract

Introduction: Dexmedetomidine hydrochloride, an imidazole compound is the pharmacologically active s-enantiomer of medetomidine. It is described chemically as (+)-4-(s)[2, 3 – (dimethylphenyl) ethyl] – 11 H-imidazole monohydrochloride. Methodology: This study was carried out on 60 patients (30 in each group) belonging to American Society of Anesthesiologists (ASA) physical status I and II and scheduled for elective general surgical, urological and gynecological surgeries. Results: In group C (Control), the basal mean SBP was 123.97±11.44. 10 min after bolus drug administration the mean SBP was 125.40±10.97 which is not statistically significant (p=0.232). In group D (Dexmedetomidine), the basal mean SBP was 126.53±9.06. 10 min after bolus drug administration and after induction the mean SBP were 108.07±10.13 and 107.03±9.95 representing a significant fall in SBP (p=0.000). Conclusion: There was marked decrease in SBP, DBP and MAP 10 min after dexmedetomidine administration. 


References

No records found.


About this article


Cite this article


Licence:




Received Accepted Published
N/A N/A N/A

DOI: http://dx.doi.org/10.21088/ijaa.2349.8471.4317.51

Keywords

Blood Pressure; Dexmedetomidine; Laroscopy.

Article Level Metrics

Last Updated

Tuesday 14 July 2026, 07:43:56 (IST)


5689

Accesses

6
679
00

Citations


NA
NA
NA

Download citation


Article Keywords


Keyword Highlighting

Highlight selected keywords in the article text.


Timeline


Received N/A
Accepted N/A
Published N/A

licence



Access this article



Share